Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,744 | -35,317 | -19,688 | 1,702 | N/A |
| Depreciation Amortization | 3,320 | 4,012 | 5,096 | 5,830 | N/A |
| Accounts receivable | -3,809 | -865 | -1,047 | -171 | N/A |
| Accounts payable and accrued liabilities | 2,253 | 209 | -473 | 874 | N/A |
| Other Working Capital | -23,264 | 42,606 | -26,903 | -21,663 | N/A |
| Other Operating Activity | 12,221 | 2,038 | 5,942 | 275 | 0 |
| Operating Cash Flow | $-65,023 | $12,683 | $-37,073 | $-13,153 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,481 | -1,557 | -3,316 | -4,378 | N/A |
| Purchase Of Investment | -196,226 | -81,463 | -14,220 | -52,304 | N/A |
| Sale Of Investment | 148,576 | 2,750 | 50,058 | 66,273 | N/A |
| Other Investing Activity | 0 | 80 | 80 | 0 | 0 |
| Investing Cash Flow | $-51,131 | $-80,190 | $32,602 | $9,591 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 15,000 | 0 | N/A |
| Debt Repayment | -5,000 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 180 | 84,570 | 95 | 184 | N/A |
| Other Financing Activity | 636 | 86,215 | -457 | -7 | 0 |
| Financing Cash Flow | $-4,184 | $170,785 | $14,638 | $177 | $N/A |
| Beginning Cash Position | 125,313 | 22,035 | 11,868 | 15,253 | N/A |
| End Cash Position | 4,975 | 125,313 | 22,035 | 11,868 | N/A |
| Net Cash Flow | $-120,338 | $103,278 | $10,167 | $-3,385 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,023 | 12,683 | -37,073 | -13,153 | N/A |
| Capital Expenditure | -3,481 | -1,557 | -3,316 | -4,394 | N/A |
| Free Cash Flow | -68,504 | 11,126 | -40,389 | -17,547 | 0 |